Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
- Chimera Biotec
- Emil-Figge-Str. 76A
- Dortmund , 44227
Chimera Biotec develops and markets solutions for bio-analytical assays based on Imperacer®, an innovative assay system for ultra-sensitive analyte detection. Imperacer® quantitatively detects molecules such as proteins and metabolites in complex biological samples while extending the dynamic range of any immunoassay by orders of magnitude.